BrightPath Biotherapeutics Company
BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies.
Technology:
Tumor-Associated Antigens, Tumor-Specific Antigens
Industry:
Peptides and Proteins
Headquarters:
Kurume, Fukuoka, Japan
Founded Date:
2003-05-08
Employees Number:
1-10
Funding Status:
IPO
Investors Number:
8
Total Funding:
4439659
Estimated Revenue:
Less than $1M
Last Funding Date:
2014-08-29
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership